261
Views
1
CrossRef citations to date
0
Altmetric
Reports

Comparing National Methadone Equianalgesic Tools

Pages 246-250 | Received 31 Oct 2022, Accepted 20 Mar 2023, Published online: 03 Apr 2023

References

  • Wen RY, Atayee RS, Edmonds KP. A comparison of institutional opioid equianalgesia tools: a national study. J Palliat Med. 2022;25(11):1686–91.
  • McPherson ML, Walker KA, Davis MP, Bruera E, Reddy A, Paice J, Malotte K, Lockman DK, Wellman C, Salpeter S, et al. Safe and appropriate use of methadone in hospice and palliative care: expert consensus white paper. J Pain Symptom Manage. 2019;57(3):635–45 e4. doi:10.1016/j.jpainsymman.2018.12.001.
  • Fishman SM, Wilsey B, Mahajan G, Molina P. Methadone reincarnated: novel clinical applications with related concerns. Pain Med. 2002;3(4):339–48. doi:10.1046/j.1526-4637.2002.02047.x.
  • Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet. 2002;41(14):1153–93. doi:10.2165/00003088-200241140-00003.
  • Jamison RN, Kauffman J, Katz NP. Characteristics of methadone maintenance patients with chronic pain. J Pain Symptom Manage. 2000;19(1):53–62. doi:10.1016/s0885-3924(99)00144-x.
  • Davis MP, Walsh D. Methadone for relief of cancer pain: a review of pharmacokinetics, pharmacodynamics, drug interactions and protocols of administration. Support Care Cancer. 2001;9(2):73–83. doi:10.1007/s005200000180.
  • Edmonds KP, Saunders IM, Willeford A, Ajayi TA, Atayee RS. Emerging challenges to the safe and effective use of methadone for cancer-related pain in paediatric and adult patient populations. Drugs. 2020;80(2):115–30. doi:10.1007/s40265-019-01234-6.
  • Pereira J, Lawlor P, Vigano A, Dorgan M, Bruera E. Equianalgesic dose ratios for opioids. a critical review and proposals for long-term dosing. J Pain Symptom Manage. 2001;22(2):672–87. doi:10.1016/s0885-3924(01)00294-9.
  • Ayonrinde OT, Bridge DT. The rediscovery of methadone for cancer pain management. Med J Aust. 2000;173(10):536–40. doi:10.5694/j.1326-5377.2000.tb139323.x.
  • Wong E, Walker KA. A review of common methods to convert morphine to methadone. J Community Hosp Intern Med Perspect. 2012;2(4):1–5.
  • McCormick BY, Fisch MJ. Methadone use in the hospice setting: safe, effective, cost-efficient. https://web.archive.org/web/20040222050742/http:/www.nhpco.org/files/public/8A.pdf. Accessed October 21, 2022.
  • Ripamonti C, Groff L, Brunelli C, Polastri D, Stavrakis A, De Conno F. Switching from morphine to oral methadone in treating cancer pain: what is the equianalgesic dose ratio? J Clin Oncol. 1998;16(10):3216–21. doi:10.1200/JCO.1998.16.10.3216.
  • Mercadante S, Caraceni A. Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med. 2011;25(5):504–15. doi:10.1177/0269216311406577.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.